sacituzumab govitecan
gilead sciences
['mbc']
tropics2 presented by . practice change for hr+ her2- mbc after use of cdk4/6i. sacituzumab, trop2-adc. so what does this mean? we will need to determine this after seeing the db-04 study. hr 0.66 #asco22 
MD Anderson Cancer Ctr, Breast Med Oncologist, Section Chief of Translational Breast Cancer Research, Executive Director of IBC Program